Just in Time for the Holidays: FDA’s Updated Guidance on CBD Amid More Warning Letters

FDA Update Despite the impending Thanksgiving holiday, the U.S. Food and Drug Administration (“FDA”) kept plenty busy this week in keeping the hemp industry on its toes issuing: (a) yet another round of a whopping fifteen (15) warning letters to companies purportedly marketing “unapproved new drugs” containing hemp-derived cannabidiol (“CBD”) in violation of FDA regulations;

By |2019-12-18T13:08:47-07:00December 5th, 2019|Government and Policy|

Holistic Pet Wellness And Hemp CBD

A Legal Perspective - by Heidi Mehaffey, Esq. and Contributions by Bridget Hill-Zayat, Esq * This article first appeared on ECRM.com  In a day and age where the majority of families own pets of all shapes and sizes, it should be no surprise that pet parents in the United States are estimated to spend more

By |2019-12-18T11:43:55-07:00November 7th, 2019|Hemp|